Bulletin of Experimental Biology and Medicine

, Volume 127, Issue 4, pp 410–412 | Cite as

Suppressive and antitumor activities of bone marrow cells and splenocytes of AKR mice during aging

  • Yu. P. Bel'skii
  • N. V. Bel'skaya
  • M. G. Danilets
  • E. S. Stal'bovskaya
  • S. A. Kusmartsev
Oncology
  • 20 Downloads

Abstract

In 4-month-old leukemia-prone AKR mice, the ability of bone marrow cells to inhibit proliferation of concanavalin A-stimulated splenocytes and mastocytoma P815 cellsin vitro was sharply increased in the preleukemic period. In 7-month-old mice, differences in natural suppressive activity of bone marrow cells were significant, but less pronounced than in 4-month-old mice. The immunosuppressive activity was not found in the spleen. In 4-month-old AKR mice, in the inhibition of proliferation of mitogen-stimulated splenocytes was increased due to enhanced NO production by bone marrow cells. These findings suggest that the increased antiproliferative activity observed in the bone marrow of AKR mice long before the appearance of clinical manifestations of leukemia is associated with disturbances in differentiation of myeloid progenitor cells and accumulation of natural suppressor cells in the bone marrow.

Key Words

natural suppressor cells nitric oxide leukemia granulocyte-macrophage precursors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. D. Gol'dberg, Yu. P. Bel'skii, M. G. Danilets,et al., Byull. Eksp. Biol. Med.,125, No. 3, 266–268 (1998).CrossRefGoogle Scholar
  2. 2.
    I. Angulo, R. Rodriguez, B. Garcia,et al., J. Immunol.,155, 15–26 (1995).PubMedGoogle Scholar
  3. 3.
    L. C. Green, D. A. Wagner, J. Glogowski,et al., Anal. Biochem.,126, 131–143 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    S. C. Moore, S. A. Theus, J. B. Barnett, and L. S. F. Soderberg,Exp. Hematol.,20, 11780–1183 (1992).Google Scholar
  5. 5.
    J. L. Subiza, J. E. Vinuela, R. Rodriguez,et al., Int. J. Cancer,44, 307–314 (1989).PubMedGoogle Scholar
  6. 6.
    K. Sugiura, M. Inaba, H. Ogata,et al., Cancer Res.,50, 2582–2586 (1990).PubMedGoogle Scholar
  7. 7.
    M. R. I. Young, G. Mccloskey, M. A. wright, and A. S. Pak,Cancer Immunol. Immunother.,38, 9–15 (1994).PubMedGoogle Scholar
  8. 8.
    M. R. I. Young, M. A. Wright, M. Coogan,et al.——Ibid.,35, 14–18 (1992).PubMedCrossRefGoogle Scholar
  9. 9.
    M. R. I. Young, M. A. Wright, and M. E. Young,——Ibid.,,33, 146–152 (1991).PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • Yu. P. Bel'skii
    • 1
  • N. V. Bel'skaya
    • 1
  • M. G. Danilets
    • 1
  • E. S. Stal'bovskaya
    • 1
  • S. A. Kusmartsev
    • 1
  1. 1.Laboratory of Experimental Biomedical Modeling, Tomsk Research CenterSiberian Division of the Russian Academy of Medical SciencesTomsk

Personalised recommendations